# Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

> **NCT00083083** · PHASE2 · UNKNOWN · sponsor: **American College of Radiology Imaging Network** · enrollment: 250 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** docetaxel
- **DRUG:** etoposide
- **DRUG:** paclitaxel
- **DRUG:** vinblastine sulfate
- **DRUG:** vinorelbine tartrate
- **GENETIC:** gene expression analysis
- **PROCEDURE:** positron emission tomography
- **RADIATION:** fludeoxyglucose F 18
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00083083
- **Lead sponsor:** American College of Radiology Imaging Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-03
- **Primary completion:** 2006-06
- **Final completion:** —
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2011-03-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00083083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00083083, "Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00083083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*